Blunted Response to Combination Antiretroviral Therapy in HIV Elite Controllers: An International HIV Controller Collaboration-Reference-Cited by-同舟云学术

Blunted Response to Combination Antiretroviral Therapy in HIV Elite Controllers: An International HIV Controller Collaboration

Published:2014-01-17 Issue:1 Volume:9 Page:e85516
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Boufassa Faroudy,Lechenadec Jérome,Meyer Laurence,Costagliola Dominique,Hunt Peter W.,Pereyra Florencia,Deeks Steve,Pancino Gianfranco,Taulera Olivier,Lichterfeld Mathias,Delobel Pierre,Saez-Cirion Asier,Lambotte Olivier,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice;G Touloumi;J Asquir Immune Defic Syndr,2008

2. Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy;PW Hunt;AIDS,2003

3. for the AIDS Clinical Trial Group 364 Study Team. Changes in slope of the CD4 cell count increase after initiation of potent antiretroviral treatment;RJ Bosch;J Acquir Immune Defic Syndr,2006

4. Immunologic and clinical responses to HAART over a 50 years of age. Results from the French Hospital Database on HIV;S Grabar;AIDS,2004

5. Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy;E Wood;AIDS,2000

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size;PLOS Pathogens;2023-11-29

2. Non-AIDS-Defining Events in Human Immunodeficiency Virus Controllers Versus Antiretroviral Therapy–Controlled Patients: A Cohort Collaboration From the French National Agency for Research on AIDS CO21 (CODEX) and CO06 (PRIMO) Cohorts;Open Forum Infectious Diseases;2023-02-01

3. Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection;2023-01-11

4. Host variation in type I interferon signaling genes (MX1), C–C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size;AIDS;2022-11-18

5. Non-AIDS Events in Individuals With Spontaneous Control of HIV-1: A Systematic Review;JAIDS Journal of Acquired Immune Deficiency Syndromes;2022-11-01